Table 2 Patient characteristics by exposure status
Characteristics | Patient was on pazopanib N = 23 | Patient was not on pazopanib N = 182 | p |
|---|---|---|---|
Age, years | |||
Mean + SD | 40.63 + 3.23 | 43. 81 + 1.45 | 0.456 |
Gender | |||
Male | 11 (48%) | 95 (52%) | |
Female | 12 (52%) | 87 (48%) | 0.693 |
Race | |||
White | 18 (78%) | 122 (67%) | |
African American | 3 (13%) | 21 (12%) | |
Hispanic/other | 2 (9%) | 39 (21%) | 0.355 |
Cavitary lung nodules/masses | |||
Yes | 10 (43%) | 52 (29%) | |
No | 13 (57%) | 130 (71%) | 0.142 |
Pleural-based lung nodules/masses | |||
Yes | 14 (61%) | 83 (46%) | |
No | 9 (39%) | 99 (54%) | 0.167 |
Emphysema present | |||
Yes | 0 (0%) | 3 (2%) | |
No | 23 (100%) | 179 (98%) | 0.535 |
Prior radiation to the chest | |||
Yes | 0 (0%) | 3 (2%) | |
No | 23 (100%) | 179 (98%) | 0.535 |
Patient developed pneumothorax | |||
Yes | 8 (35%) | 33 (18%) | |
No | 15 (65%) | 149 (82%) | 0.060 |